ArticleCancer science2022

lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2-mediated PI3K/AKT pathway in glioma.

Jian Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.